Medical Device and Diagnostic Industry (MD+DI)

Medtronic's Acquisition Spree Continues: SPR Therapeutics Joins $650M Neuromodulation Expansion

Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...
Endovascular Today

FDA Approves Reduced Shake Time for Medtronic’s Onyx 18 and Onyx 34

Medtronic Neurovascular announced that its Onyx Liquid Embolic System (LES), Onyx 18 and Onyx 34, received FDA approval for a shake ...
24/7 Wall St.

Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

Surgical robotics platforms are becoming AI-enabled systems, making Intuitive Surgical, Medtronic, and Stryker look ...
medtechintelligence

Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures

Medtronic is overhauling its cardiovascular business in a major restructuring that includes new operating divisions, ongoing acquisitions, and a strategic push into higher-growth cardiac technologies.